Total revenues of the Merck Group increased 16% to € 2,555 million in the second quarter from € 2,208 million in the year-ago quarter, boosted by the July 2010 acquisition of the Millipore Corporation, a leading life science company based in the United States. Acquisitions and divestments accounted for 13.7% points of the increase. Negative currency effects reduced revenues by 3.1%, resulting in an organic growth rate of 5.1%. For the first half of 2011, total revenues rose 19% to € 5,119 million.
Royalty, license and commission income, which is mainly attributable to the Merck Serono division, decreased 18% to € 86 million in the second quarter.
|
Components of growth by division – Q2 |
|||||
|
|
|
|
|
|
|
|
Change in total revenues |
Merck Serono |
Consumer Health Care |
Merck Millipore |
Performance Materials |
Merck Group |
|
Organic growth |
6.4 |
4.2 |
4.0 |
1.4 |
5.1 |
|
Currency effects |
–2.9 |
–0.3 |
–2.7 |
–4.9 |
–3.1 |
|
Acquisitions /divestments |
–1.5 |
– |
137.6 |
–3.0 |
13.7 |
|
Total |
2.0 |
3.9 |
138.9 |
–6.5 |
15.7 |
back
